Back to search

Article

Hypermethylation of TMEM240 Involved in Expression Deficiency Predicts Poor Hormone Therapy Response and Disease Progression in Breast Cancer

2021-11-10

Abstract excerpt

<h4>Background: </h4> Approximately 25% of patients with early-stage breast cancer experience cancer progression throughout the disease course. Alterations in TMEM240 in breast cancer were identified and investigated to monitor treatment response and disease progression. <h4>Methods: </h4>: Circulating methylated TMEM240 in the plasma of breast cancer patients was used to monitor treatment response and relapse eve...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
39da7ac5-cd50-5a41-b17b-aec007f2953e
DOI
10.21203/rs.3.rs-1021973/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Hypermethylation of TMEM240 Involved in Expression Deficiency Predicts Poor Hormone Therapy Response and Disease Progression in Breast CancerDOI 10.21203/rs.3.rs-1021973/v1
Select a neighboring publication to make it the new centre.